TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/14/24 20:53 | 3/13/24 | APRE | Aprea Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Seizinger Bernd R. | PA | D | P.d | 50 | 7.29 | 0 | 7 | 26 | 34 | D | |||||||||||||||
9/25/23 17:03 | 9/22/23 | APTO | Aptose Biosciences Inc. | A6 | Health | BioPrd | Biological Products, (No Diag | Seizinger Bernd R. | A6 | D | P | 53 | 3.14 | 0 | 17 | New | 17 | D | |||||||||||||||
6/8/23 16:34 | 6/6/23 | APRE | Aprea Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Seizinger Bernd R. | PA | D | P.m | 37 | 3.66 | 0 | 10 | 62 | 26 | D | |||||||||||||||
5/19/22 16:31 | 5/18/22 | APRE | Aprea Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Seizinger Bernd R. | MA | D | P | 36 | 0.7100 | 0 | 50 | 19 | 319 | D | |||||||||||||||
10/7/19 19:33 | 10/7/19 | APRE | Aprea Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Seizinger Bernd R. | MA | D | M.d | 18 | 0.0700 | 0 | 264 | New | 264 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |